Transcend Medical (@TranscendMed) profile picture

Transcend Medical

@TranscendMed

Transforming the treatment of glaucoma.

 Menlo Park, CA
transcendmedical.com
Joined May 2012
  • Tweets39
  • Following35
  • Followers72
2Media
Photo by Transcend Medical (@TranscendMed)Photo by Transcend Medical (@TranscendMed)
Transcend joining @Novartis Alcon tops OIS News in Feb : Eye on Five ois.net/eye-on-five-february… via @oistweets
Eye on Five – February Edition 2016 | Ophthalmology Innovation Source

Eye on Five – February Edition 2016 | Ophthalmology Innovation Source

The Transcend acquisition tops the list, but February was a promising month for ophthalmology. Alcon Leaps into MIGS with Transcend With its acquisition

ois.net
6
3
Check out our CMO, Sean Ianchulev, presenting at last year's OIS meeting at AAO in Las Vegas @OISTWEETS @aao_ophth ois.net/transcend-aao-2015/

Transcend Medical | OIS@AAO 2015

The year 2015 represented a milestone for Transcend Medical – it completed a milestone study and filed a Premarket Approval for a minimally invasive

ois.net
3
3
Thx @canaanpartners, @WendeHutton, & all our investors for your support of the CyPass #glaucoma therapy mddionline.com/blog/deviceta… @MDDIonline
1
1
Transcend is proud to announce we will be joining @Novartis #Alcon, world leader in eye care. novartis.com/news/media-rele… #glaucoma #MIGS
4
3
What do #glaucoma and other blinding conditions really look like? Check out medicaldaily.com/visual-impa… via @medicaldaily
2
1
1
MIGS in the suprachoroidal space: three reasons why it has a bright future @DrHovanesian @Healio_OSN healio.com/ophthalmology/gla…
2
Sean Ianchulev MD describes the potential of supraciliary microstenting with the CyPass Micro-Stent #MIGS #glaucoma ophthalmologytimes.modernmed…
2
1
CyPass AJO article on DUETTE study (multicenter trial on standalone procedure) covered in recent @Healio_OSN! goo.gl/4cmytp
1
Transcend is proud to be featured on the latest OIS podcast. ois.net/transcend-medical-re… via @oistweets
Transcend Medical Ready To Make Move In MIGs | Ophthalmology Innovation Source

Transcend Medical Ready To Make Move In MIGs | Ophthalmology Innovation Source

Transcend Medical CMO Sean Ianchulev provides an update on COMPASS trial and shares company’s plan for the FDA. Podcast Guest Sean Ianchulev, MD, MPH Dr.

ois.net
1
CyPass Micro-Stent US-IDE pivotal study positive; next glaucoma stent to file PMA with FDA late 2015. transcendmedical.com/intl/in…
4
Replying to @GlaucomaWeek
@GlaucomaWeek It's World Glaucoma Week! Get yourself or a loved one screened if you are at risk. Find out more wgweek.net/what-is-glaucoma/
Our favorite CEO Brian Walsh & the CyPass Micro-Stent "transcending glaucoma treatment" featured in @MassDevice! massdevice.com/features/bria…
2
We are proud to announce the closing of a $22M Series C financing to help us complete the COMPASS U.S. pivotal study! marketwired.com/press-releas…
Our CMO, Dr. Sean Ianchulev, speaking at @GlaucomaOrg @PalaceHotelSF with a CyPass Micro-Stent update. Nice job Sean!
Image from Transcend Medical (@TranscendMed)
2-year CyPass Micro-Stent data from our European study, published in the Ophthalmology Times, and featuring our... fb.me/YwYURYRS
2-year European data on the CyPass Micro-Stent MIGS implant for glaucoma featured in @OphthTimes shar.es/UBqth
2
1
CyPass with cataract surgery safe at 2 yrs - intl data, @aao_ophth @Medscape medscape.com/viewarticle/815…
1
Dr. Brian Flowers (@FortWorth2020) shares 2-yr intl data on the CyPass Micro-Stent + phaco at AAO 2013 (@aao_ophth)
Image from Transcend Medical (@TranscendMed)
Micro-stents defining their role in glaucoma. See p.3 for CyPass shoutout by Dr. Rau and Prof García-Feijoo! tinyurl.com/l4ea6hw
1
Adherence to glaucoma drops is a huge challenge. New study shows morning administration may be best. visionaware.org/blog.aspx?Bl… via @visionaware

No more items